<html>
<head>
    <script language="JavaScript" src="http://code.jquery.com/jquery-1.4.4.js"></script>
    <script language="JavaScript" src="../js/pie.js"></script>
    <script language="JavaScript" src="../js/browser_adjust.js"></script>
    <script language="JavaScript" src="../js/search.js"></script>


    <script type="text/JavaScript">
    <!--

    var array = [[6.5542127602, "../topics/{product,_liability,_claim}.html", "{product,_liability,_claim}"], [4.8377105089, "../topics/{product,_candidate,_development}.html", "{product,_candidate,_development}"], [4.8046530548, "../topics/{stock,_price,_operating}.html", "{stock,_price,_operating}"], [4.7849196222, "../topics/{regulation,_government,_change}.html", "{regulation,_government,_change}"], [3.6910831957, "../topics/{cost,_regulation,_environmental}.html", "{cost,_regulation,_environmental}"], [3.1621734379, "../topics/{stock,_price,_share}.html", "{stock,_price,_share}"], [2.7215666302, "../topics/{acquisition,_growth,_future}.html", "{acquisition,_growth,_future}"], [2.7057836628, "../topics/{property,_intellectual,_protect}.html", "{property,_intellectual,_protect}"], [2.5401170354, "../topics/{competitive,_industry,_competition}.html", "{competitive,_industry,_competition}"], [2.2397607154, "../topics/{condition,_economic,_financial}.html", "{condition,_economic,_financial}"], [2.0143244036, "../topics/{product,_market,_service}.html", "{product,_market,_service}"], [1.7779660114, "../topics/{interest,_director,_officer}.html", "{interest,_director,_officer}"], [1.7169408185, "../topics/{tax,_income,_asset}.html", "{tax,_income,_asset}"], [1.712786567, "../topics/{regulation,_change,_law}.html", "{regulation,_change,_law}"], [1.7052028935, "../topics/{system,_service,_information}.html", "{system,_service,_information}"], [1.7001493155, "../topics/{control,_financial,_internal}.html", "{control,_financial,_internal}"], [1.6968271936, "../topics/{personnel,_key,_retain}.html", "{personnel,_key,_retain}"], [1.6604500735, "../topics/{capital,_credit,_financial}.html", "{capital,_credit,_financial}"]];
    var elements = generate_pie_elements(array);
    var piec = null;
    function init() {
        browser_adjust();
        
        // create pie chart
        piec = new PieChart(elements);
        piec.initialize();

    }

    function highlight(i) {
        piec.highlight(i);
    }
    
    function unhighlight() {
        piec.unhighlight();
    }
    //-->
    </script>

    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    
    <title>1383183--3/18/2010--CombiMatrix_Corp</title>

    <link href="../styling.css" rel="stylesheet" type="text/css">
</head>

<body onLoad="init()">
<div id="navigation">
<hr noshade>
<table><tr>
    <td class="navtext">Browse&nbsp;&#x25B8;</td> 
    <td class="linked"><a>Topics</a>
      <ul> 
        <li><a href="../browse/topic-list.html">List of Terms</a></li> 
        <li><a href="../browse/topic-graph.html">Term Distributions</a></li> 
        <li><a href="../browse/topic-presence.html">Relative Presence</a></li>
      </ul> 
    </td> 
    <td class="linked"><a>Documents</a>
      <ul>
        <li><a href="../browse/doc-graph.html">Topic Distributions</a></li>
      </ul> 
    </td>
    <td class="linked"><a>Terms</a>
      <ul> 
        <li><a href="../browse/term-list.html">List by Frequency</a></li> 
        <li><a href="../browse/term-graph.html">Topic Distributions</a></li> 
       </ul> 
    </td>
    <td class="linked"><a>About</a>
      <ul>
        <li><a href="http://www.cs.princeton.edu/~blei/lda-c/">LDA</a></li>
      </ul> 
    </td>
    
    </td>
    <td></td>
    <td class="searchbar"> Search&nbsp;&#x25B8;</td>
    <td class="searchbar"><input type="text" name="search" size="20" onkeypress="handleKeyPress(event)"><span onclick="doSearch()"></span>
    </td>
</tr></table>
</div>

    <div id="top"></div>

    <h1 id="header">
        <table><tr>
            <td id="title">1383183--3/18/2010--CombiMatrix_Corp</td>
        </tr></table>

        <hr noshade>
    </h1>

    <div id="main">
        <table><tr>
            <td width="210px">
                <table class="dark">
                <tr><td><canvas id="canvas" width="200" height="200"></canvas></td></tr>
                <tr class="title">
                    <td>related topics</td>
                </tr>
                <tr class="list"><td id="{product,_liability,_claim}" onmouseover="highlight(0)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{product,_liability,_claim}.html'">{product, liability, claim}</td></tr>
<tr class="list"><td id="{product,_candidate,_development}" onmouseover="highlight(1)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{product,_candidate,_development}.html'">{product, candidate, development}</td></tr>
<tr class="list"><td id="{stock,_price,_operating}" onmouseover="highlight(2)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{stock,_price,_operating}.html'">{stock, price, operating}</td></tr>
<tr class="list"><td id="{regulation,_government,_change}" onmouseover="highlight(3)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{regulation,_government,_change}.html'">{regulation, government, change}</td></tr>
<tr class="list"><td id="{cost,_regulation,_environmental}" onmouseover="highlight(4)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{cost,_regulation,_environmental}.html'">{cost, regulation, environmental}</td></tr>
<tr class="list"><td id="{stock,_price,_share}" onmouseover="highlight(5)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{stock,_price,_share}.html'">{stock, price, share}</td></tr>
<tr class="list"><td id="{acquisition,_growth,_future}" onmouseover="highlight(6)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{acquisition,_growth,_future}.html'">{acquisition, growth, future}</td></tr>
<tr class="list"><td id="{property,_intellectual,_protect}" onmouseover="highlight(7)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{property,_intellectual,_protect}.html'">{property, intellectual, protect}</td></tr>
<tr class="list"><td id="{competitive,_industry,_competition}" onmouseover="highlight(8)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{competitive,_industry,_competition}.html'">{competitive, industry, competition}</td></tr>
<tr class="list"><td id="{condition,_economic,_financial}" onmouseover="highlight(9)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{condition,_economic,_financial}.html'">{condition, economic, financial}</td></tr>
<tr class="list"><td id="{product,_market,_service}" onmouseover="highlight(10)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{product,_market,_service}.html'">{product, market, service}</td></tr>
<tr class="list"><td id="{interest,_director,_officer}" onmouseover="highlight(11)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{interest,_director,_officer}.html'">{interest, director, officer}</td></tr>
<tr class="list"><td id="{tax,_income,_asset}" onmouseover="highlight(12)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{tax,_income,_asset}.html'">{tax, income, asset}</td></tr>
<tr class="list"><td id="{regulation,_change,_law}" onmouseover="highlight(13)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{regulation,_change,_law}.html'">{regulation, change, law}</td></tr>
<tr class="list"><td id="{system,_service,_information}" onmouseover="highlight(14)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{system,_service,_information}.html'">{system, service, information}</td></tr>
<tr class="list"><td id="{control,_financial,_internal}" onmouseover="highlight(15)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{control,_financial,_internal}.html'">{control, financial, internal}</td></tr>
<tr class="list"><td id="{personnel,_key,_retain}" onmouseover="highlight(16)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{personnel,_key,_retain}.html'">{personnel, key, retain}</td></tr>
<tr class="list"><td id="{capital,_credit,_financial}" onmouseover="highlight(17)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{capital,_credit,_financial}.html'">{capital, credit, financial}</td></tr>

                </table>
            </td>

            <td>
                <table class="light">
                <tr class="doc"><td>
                    Risks Related To Our Business
We may not be able to meet our cash requirements beyond June 2011 without obtaining additional capital from external sources, and if we are unable to do so, we may not be able to continue as a going concern.
We may need to raise additional capital in the future, and if additional capital is not available on acceptable terms, we may have to curtail or cease operations.
We have a history of losses and expect to incur additional losses in the future.
If our stock price declines, this could result in a goodwill impairment.
The recent financial crisis could negatively affect our business, results of operations and financial condition.
Because our business operations are subject to many uncontrollable outside influences, we may not succeed.
Our revenues will be unpredictable, and this may harm our financial condition.
We are deploying new and unproven technologies, which makes evaluation of our business and prospects difficult, and we may be forced to cease operations if we do not develop commercially successful products.
The genetic diagnostic laboratory market is characterized by rapid technological change, frequent new product introductions, and evolving industry standards, and we may encounter difficulties keeping pace with changes in this market.
If we do not enter into successful partnerships and collaborations with other companies, we may not be able to fully develop our technologies or products, and our business would be harmed.
We have limited experience commercially manufacturing, marketing, or selling any of our potential products and services, and unless we develop these capabilities, we may not be successful.
We face intense competition, and we cannot assure you that we will be successful competing in the market.
If our new and unproven technology is not used by researchers in the pharmaceutical, biotechnology and academic communities, or by physicians and laboratories in the diagnostics market, our business will suffer.
A significant component of our revenue is dependent on successful insurance claims. Our revenue will be diminished if payors do not adequately cover or reimburse us for our services.
Our cash flows and financial condition may decline if payors do not reimburse us for our services in a timely manner.
Third party billing is extremely complicated and could result in us incurring significant additional costs.
Complying with numerous regulations pertaining to our business is an expensive and time-consuming process, failure of which could result in significant penalties and our suspension of one or more licenses.
Loss of or adverse changes to our accreditations or licenses could materially and adversely affect our business, prospects and results of operations.
We are subject to significant environmental, health and safety regulation.
We are subject to federal and state laws governing the financial relationship among healthcare providers, including Medicare Medicaid laws, and our failure to comply with these laws could result in significant penalties and other adverse consequences.
Our business is subject to stringent laws and regulations governing the privacy, security and transmission of medical information, and our failure to comply could subject us to criminal penalties and civil sanctions.
Our product development efforts may be hindered if we are unable to gain access to patients' tissue and blood samples.
If our current laboratory facility becomes inoperable or loses certification, we will be unable to perform our tests and our business will be harmed.
Our future success depends on the continued service of our engineering, technical and key management personnel and our ability to identify, hire and retain additional engineering, technical and key management personnel.
The expansion of our product lines may subject us to regulation by the FDA and foreign regulatory authorities, of which regulation could prevent or delay our introduction of new products.
As our operations expand, our costs to comply with environmental laws and regulations will increase, and failure to comply with these laws and regulations could harm our financial results.
Our business depends on issued and pending patents, and the loss of any patents or our failure to secure the issuance of patents covering elements of our business processes could materially harm our business and financial condition.
Any litigation to protect our intellectual property, or any third-party claims of infringement, could divert substantial time and money from our business and could shut down some of our operations.
We could face substantial liabilities if we are sued for product liability.
Failure to effectively manage our growth could place strains on our managerial, operational and financial resources and could adversely affect our business and operating results.
Our future success depends on our ability to expand our organization to match the growth of our subsidiaries.
As a public company, we are subject to complex legal and accounting requirements that will require us to incur substantial expense and will expose us to risk of non-compliance.
Ethical, legal and social concerns surrounding the use of genetic information could reduce demand for our products.
Risks Related To Investment In Our Securities
Technology company stock prices are especially volatile, and this volatility may depress the price of our stock.
While warrants to purchase our common stock are outstanding, it may be more difficult to raise additional equity capital.
Future sales or the potential for future sales of our securities may cause the trading price of our common stock to decline and could impair our ability to raise capital through subsequent equity offerings.
We may fail to meet market expectations because of fluctuations in our quarterly operating results, all of which could cause our stock price to decline.
Risks Related To Our Split-Off From Acacia Research Corporation
Our separation agreements with Acacia require us to assume the past, present and future liabilities related to our business and may be less favorable to us than if they had been negotiated with unaffiliated third parties.
<p><a href="http://www.sec.gov/Archives/edgar/data/1383183/0001047469-10-002423.txt">Full 10-K form&nbsp;&#x25B8;</a></p>
                </td></tr>
                </table>
            </td>

            <td width="25%">
                <table class="dark">
                <tr class="title">
                    <td>related documents</td>
                </tr>
                <tr class="list"><td onclick="window.location.href='../docs/881464--2-27-2009--AMYLIN_PHARMACEUTICALS_INC.html'">881464--2/27/2009--AMYLIN_PHARMACEUTICALS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/784199--2-19-2009--CRYOLIFE_INC.html'">784199--2/19/2009--CRYOLIFE_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/784199--2-19-2010--CRYOLIFE_INC.html'">784199--2/19/2010--CRYOLIFE_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1105184--3-11-2010--NANOSPHERE_INC.html'">1105184--3/11/2010--NANOSPHERE_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1318310--2-27-2009--ev3_Inc..html'">1318310--2/27/2009--ev3_Inc.</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1318310--2-25-2010--ev3_Inc..html'">1318310--2/25/2010--ev3_Inc.</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1383183--3-19-2008--CombiMatrix_Corp.html'">1383183--3/19/2008--CombiMatrix_Corp</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1138723--9-10-2008--ACCURAY_INC.html'">1138723--9/10/2008--ACCURAY_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/881464--2-26-2010--AMYLIN_PHARMACEUTICALS_INC.html'">881464--2/26/2010--AMYLIN_PHARMACEUTICALS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1383183--3-27-2009--CombiMatrix_Corp.html'">1383183--3/27/2009--CombiMatrix_Corp</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/881464--2-26-2007--AMYLIN_PHARMACEUTICALS_INC.html'">881464--2/26/2007--AMYLIN_PHARMACEUTICALS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/864683--7-6-2007--CYBERONICS_INC.html'">864683--7/6/2007--CYBERONICS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/884629--3-1-2007--WATSON_PHARMACEUTICALS_INC.html'">884629--3/1/2007--WATSON_PHARMACEUTICALS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/883975--3-11-2010--STEMCELLS_INC.html'">883975--3/11/2010--STEMCELLS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1040666--3-16-2009--VNUS_MEDICAL_TECHNOLOGIES_INC.html'">1040666--3/16/2009--VNUS_MEDICAL_TECHNOLOGIES_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1012140--2-23-2010--ONYX_PHARMACEUTICALS_INC.html'">1012140--2/23/2010--ONYX_PHARMACEUTICALS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1230355--3-13-2009--TRANS1_INC.html'">1230355--3/13/2009--TRANS1_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1116463--3-12-2008--ORASURE_TECHNOLOGIES_INC.html'">1116463--3/12/2008--ORASURE_TECHNOLOGIES_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/863680--3-31-2009--CARDIOGENESIS_CORP_-CA.html'">863680--3/31/2009--CARDIOGENESIS_CORP_/CA</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/319240--3-16-2010--IRIS_INTERNATIONAL_INC.html'">319240--3/16/2010--IRIS_INTERNATIONAL_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1230355--3-25-2008--TRANS1_INC.html'">1230355--3/25/2008--TRANS1_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/789132--3-15-2010--SPECTRANETICS_CORP.html'">789132--3/15/2010--SPECTRANETICS_CORP</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/884629--2-23-2009--WATSON_PHARMACEUTICALS_INC.html'">884629--2/23/2009--WATSON_PHARMACEUTICALS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1105184--3-21-2008--NANOSPHERE_INC.html'">1105184--3/21/2008--NANOSPHERE_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1105184--2-26-2009--NANOSPHERE_INC.html'">1105184--2/26/2009--NANOSPHERE_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1124140--3-12-2010--EXACT_SCIENCES_CORP.html'">1124140--3/12/2010--EXACT_SCIENCES_CORP</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/789132--3-17-2008--SPECTRANETICS_CORP.html'">789132--3/17/2008--SPECTRANETICS_CORP</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1040666--3-30-2007--VNUS_MEDICAL_TECHNOLOGIES_INC.html'">1040666--3/30/2007--VNUS_MEDICAL_TECHNOLOGIES_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/884629--2-25-2008--WATSON_PHARMACEUTICALS_INC.html'">884629--2/25/2008--WATSON_PHARMACEUTICALS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/776008--3-16-2010--STAR_SCIENTIFIC_INC.html'">776008--3/16/2010--STAR_SCIENTIFIC_INC</td></tr>

                </table>
            </td>
        </tr></table>
    </div>

    <div id="footer">
        <br>
        <hr noshade>
    </div>
</body>
</html>
